Source: FinanzNachrichten

Aavantgarde: Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer

MILAN, ITALY / ACCESSWIRE / June 30, 2022 / AAVantgarde Bio, a biotechnology start-up that is developing gene therapies for inherited retinal disorders based on Adeno-Associated Viral (AAV) vectors...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Natalia Misciattelli Mocenigo Soranzo's photo - CEO of Aavantgarde

CEO

Natalia Misciattelli Mocenigo Soranzo

CEO Approval Rating

90/100

Read more